- Filed
- May 20, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 20, 2024 | 20.07M sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $41.99K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $1.01K |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$2.09M |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2023 | −$1M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$710.95K |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $1.64M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $1.38M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $2.14M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $1.88M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $48.16K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $13.48K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $49.76K |
| Total Assets | Q1 2024 · Dec 31, 2023 | $15.08K |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 15.64M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$202.96K |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.02 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.02 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $106.35K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$292.02K |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$264.78K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $107.92K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $209.76K |
| Revenue | Q1 2024 · Mar 31, 2023 | $317.68K |